Normative data of the Montreal Cognitive Assessment for the blind (MoCA-22) for the Czech population
Authors:
M. Kvapilová 1; O. Bezdíček 1,2; H. Georgi 2; M. Kopeček 3,4
Authors‘ workplace:
Neurologická klinika a Centrum klinických neurověd, 1. LF UK a VFN v Praze
1; Pražská vysoká škola psychosociálních, studií
2; Národní ústav duševního zdraví, Klecany
3; Klinika psychiatrie a lékařské psychologie, 3. LF UK v Praze
4
Published in:
Cesk Slov Neurol N 2025; 88(1): 58-62
Category:
Original Paper
doi:
https://doi.org/10.48095/cccsnn202558
Overview
Aim: The Montreal Cognitive Assessment (MoCA) is one of the most widely used cognitive screening tests in adults with reference standards for the Czech population. The MoCA-22 variant is designed for individuals with visual impairment or upper limb immobility and can be administered over the telephone. This study presents the Czech MoCA-22 normative standards. Materials and methods: The sample (N = 1,049) consists of participants from four studies conducted in the Czech Republic. The subjects included were aged 19–98 years, and were without neurodegenerative, psychiatric, or other serious illness. Data for the MoCA-22 were derived from data obtained by the standard version of MoCA. Following established clinical practice and statistical analysis, the population and derived norms are divided into three age categories: 19–50 years, 51–74 years, and 75 years and older. Results: For these age categories above, which were further subdivided by educational status (lower, higher), we present mean scores and estimated percentile thresholds. Performance in the MoCA-22 is affected by demoraphic factors, such as educational status and age but not sex, as reflected by the regression equation. Conclusions: Normative data for MoCA-22 will complement the clinical armamentarium in Czechia and allow adequate cognitive screening in people whose health status limits them when using standard methods.
Keywords:
Montreal Cognitive Assessment – screening – immobility – Telemedicine – normative data – blind – phone
Sources
1. Rabin LA, Paolillo E, Barr WB. Stability in test-usage practices of clinical neuropsychologists in the United States and Canada over a 10-year period: a follow-up survey of INS and NAN members. Arch Clin Neuropsychol 2016; 31 (3): 206–230. doi: 10.1093/arclin/acw007.
2. Nasreddine ZS, Phillips NA, Bedirian V et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53 (4): 695–699.
3. Reban J. Montrealsky kognitivni test/MoCA/: prinos k diagnostice predemenci. Čes Ger Rev 2006; 4: 224–229.
4. Kopecek M, Stepankova H, Lukavsky J et al. Montreal cognitive assessment (MoCA): Normative data for old and very old Czech adults. Appl Neuropsychol Adult 2017; 24 (1): 23–29. doi: 10.1080/23279095.2015.1065261.
5. Bartos A, Fayette D. Validation of the Czech Montreal Cognitive Assessment for mild cognitive impairment due to Alzheimer disease and Czech norms in 1,552 elderly persons. Dement Geriatr Cogn Disord 2018; 46 (5–6): 335–345. doi: 10.1159/000494489.
6. Bartos A, Orlikova H, Raisova M et al. Czech training version of the Montreal Cognitive Assessment (MoCA-CZ1) for early identification of Alzheimer disease. Cesk Slov Neurol N 2014; 77 (5): 587–595.
7. Bezdicek, Balabanova P, Havrankova P et al. A comparison of the Czech version of the Montreal Cognitive Assessment Test with the Mini Mental State Examination in identifying cognitive deficits in Parkinson‘s disease. Cesk Slov Neurol N 2010; 73 (2): 150–156.
8. Bezdicek O, Majerova V, Novak M et al. Validity of the Montreal Cognitive Assessment in the detection of cognitive dysfunction in Huntington‘s disease. Appl Neuropsychol Adult 2013; 20 (1): 33–40. doi: 10.1080/09084282.2012.670158.
9. Bezdicek O, Červenková M, Moore TM et al. Determining a short form Montreal Cognitive Assessment (s-MoCA) Czech version: validity in mild cognitive impairment Parkinson‘s disease and cross-cultural comparison. Assessment 2020; 27 (8): 1960–1970. doi: 10.1177/1073191118778896.
10. Bezdícek O, Georgi H, Paneková Eet al. Equivalence of Montreal Cognitive Assessment alternate forms. Cesk Slov Neurol N 2019; 82 (3): 332–340. doi: 10.14735/amcsnn2019332.
11. Kopecek M, Bezdicek O, Sulc Z et al. Montreal Cognitive Assessment and Mini-Mental State Examination reliable change indices in healthy older adults. Int J Geriatr Psychiatry 2017; 32 (8): 868–875. doi: 10.1002/gps.4539.
12. Ratcliffe LN, Hale AC, McDonald T et al. The Montreal Cognitive Assessment: norms and reliable change indices for standard and MoCA-22 administrations. Arch Clin Neuropsychol 2024; 39 (6): 747–465. doi: 10.1093/arclin/acae013.
13. Benge JF, Kiselica AM. Rapid communication: preliminary validation of a telephone adapted Montreal Cognitive Assessment for the identification of mild cognitive impairment in Parkinson‘s disease. Clin Neuropsychol 2021; 35 (1): 133–147. doi: 10.1080/13854046.2020.1801848.
14. Katz MJ, Wang C, Nester CO et al. T-MoCA: a valid phone screen for cognitive impairment in diverse community samples. Alzheimers Dement (Amst) 2021; 13 (1): e12144. doi: 10.1002/dad2.12144.
15. Wittich W, Phillips N, Nasreddine ZS et al. Sensitivity and apecificity of the Montreal Cognitive Assessment modified for individuals who are visually impaired. JVIB 2010; 104 (6): 360–368. doi: 10.1177/0145482X1010 400606.
16. Štěpánková H, Bezdíček O, Nikolai T et al. National Normative Study of Cognitive Determinants of Healthy Ageing-status report. E-psychologie 2015; 9 (1): 43–64.
17. Besser L, Kukull W, Knopman DS et al. Version 3 of the national Alzheimer’s coordinating center’s uniform data set. Alzheimer Dis Assoc Disord 2018; 32 (4): 351–358. doi: 10.1097/WAD.0000000000000279.
18. Wenke Š, Mana J, Havlík F et al. Characterization of memory profile in idiopathic REM sleep behavior disorder. J Clin Exp Neuropsychol 2022; 44 (3): 237–250. doi: 10.1080/13803395. 2022.2107182.
19. Lord AR, Amitrano NR, González DA. Reliability and validity of the Montreal Cognitive Assessment‘s auditory items (MoCA-22). Clin Neuropsychol 2024; 38 (3): 783–798. doi: 10.1080/13854046.2023. 2261634.
20. Yeung PY, Wong LLL, Chan CC et al. Montreal Cognitive Assessment – single cutoff achieves screening purpose. Neuropsychiatr Dis Treat 2020; 6 (16): 2681–2687. doi: 10.2147/NDT.S269243.
Labels
Paediatric neurology Neurosurgery NeurologyArticle was published in
Czech and Slovak Neurology and Neurosurgery
2025 Issue 1
Most read in this issue
- Guidelines of the Cerebrovascular Section of the Czech Neurological Society of the CMA JEP and the Czech Society for Interventional Radiology of the CMA JEP for the indication of mechanical recanalization – version 2024
- Idiopathic orofacial pain
- Options for the use of epidural stimulation in individuals with motor complete spinal cord injury
- Normative data of the Montreal Cognitive Assessment for the blind (MoCA-22) for the Czech population